Community hub
0 subscribers8 pages, 0 posts
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Contribute something
Welcome to the community hub built to collect knowledge and have discussions related to Catharanthalog.
Nothing was collected or created yet.
Catharanthalog
Catharanthalog
View on Wikipediafrom Wikipedia
Pharmaceutical compound
 | |
 | |
| Clinical data | |
|---|---|
| Other names | CAG |
| Drug class | Non-hallucinogenic serotonin 5-HT2A receptor partial agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C15H18N2O2 |
| Molar mass | 258.321 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Catharanthalog (CAG) is a non-hallucinogenic serotonin receptor modulator of the ibogalog group related to the iboga alkaloid catharanthine but with a simplified chemical structure.[1][2] It is known to act as a serotonin 5-HT2A receptor partial agonist.[2] The drug produces analgesic-like effects in a neuropathic pain model in rodents that can be reduced by the serotonin 5-HT2A receptor antagonist ketanserin.[2] Catharanthalog is said to have relatively low blood–brain barrier permeability owing to relatively low lipophilicity.[2] It does not produce the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[2] The drug was first described in the scientific literature by 2025.[1][2]
- ^ a b Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A (June 2025). "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives". ACS Chemical Neuroscience. 16 (12): 2163–2177. doi:10.1021/acschemneuro.5c00152. PMC 12183689. PMID 40474592.
In an oxaliplatin-induced neuropathic pain model, catharanthalog (CAG), noribogainalog (nor-IBG), and another ibogalog derivative, PNU-22394 also demonstrated consistent analgesic efficacy without observable toxicity.
- ^ a b c d e f Arias HR, Micheli L, Jensen AA, Galant S, Vandermoere F, Venturi D, et al. (March 2025). "Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors" (PDF). Biomedicine & Pharmacotherapy. 184 117887. doi:10.1016/j.biopha.2025.117887. PMID 39938347.
| Tryptamines |
|
|---|---|
| 4-Hydroxytryptamines and esters/ethers |
|
| 5-Hydroxy- and 5-methoxytryptamines |
|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| α-Ketotryptamines | |
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information. |